Simon Peter Cooper

Insider Reports History

Location
Lexington, MA
Signature
/s/ Robert Farrell, Attorney-in-Fact for Simon Peter Cooper
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simon Peter Cooper:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Morphic Holding, Inc. CMO Restricted Stock Unit 7K $192K $27.49 18 Mar 2024 Direct
Morphic Holding, Inc. CMO Restricted Stock Unit 0 $0 $55.79 16 Aug 2024 Direct
Morphic Holding, Inc. CMO Employee Stock Options (right to buy) 170K 18 Mar 2024 Direct
Keros Therapeutics, Inc. CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 40K 13 Feb 2024 Direct
Morphic Holding, Inc. CMO Stock Option (Right to Buy) 0 16 Aug 2024 Direct

Insider Reports Filed by Simon Peter Cooper

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MORF Morphic Holding, Inc. 16 Aug 2024 3 $0 4 CMO 20 Aug 2024, 19:02
MORF Morphic Holding, Inc. 18 Mar 2024 3 $0 4 CMO 19 Mar 2024, 19:07
MORF Morphic Holding, Inc. 18 Mar 2024 0 $0 3 CMO 19 Mar 2024, 19:05
KROS Keros Therapeutics, Inc. 13 Feb 2024 1 $0 4 CHIEF MEDICAL OFFICER 15 Feb 2024, 20:37
KROS Keros Therapeutics, Inc. 16 Feb 2023 1 $0 4 Chief Medical Officer 17 Feb 2023, 15:15
KROS Keros Therapeutics, Inc. 21 Jan 2022 1 $0 4 Chief Medical Officer 25 Jan 2022, 15:12
KROS Keros Therapeutics, Inc. 10 Aug 2021 1 $0 4 Chief Medical Officer 11 Aug 2021, 16:56
KROS Keros Therapeutics, Inc. 02 Aug 2021 0 $0 3 Chief Medical Officer 11 Aug 2021, 16:54